ID22625A - Modifikasi kristal baru dari cdch, suatu proses untuk preparatnya dan formulasi farmasi terdiri dari modifikasi - Google Patents

Modifikasi kristal baru dari cdch, suatu proses untuk preparatnya dan formulasi farmasi terdiri dari modifikasi

Info

Publication number
ID22625A
ID22625A IDP963684A ID963684A ID22625A ID 22625 A ID22625 A ID 22625A ID P963684 A IDP963684 A ID P963684A ID 963684 A ID963684 A ID 963684A ID 22625 A ID22625 A ID 22625A
Authority
ID
Indonesia
Prior art keywords
modification
cdch
preparation
formulation containing
new crystals
Prior art date
Application number
IDP963684A
Other languages
English (en)
Indonesian (id)
Inventor
Alfons Dr Grunenberg
Patrick Dr Bosche
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7779831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID22625(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ID22625A publication Critical patent/ID22625A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDP963684A 1995-12-12 1996-12-10 Modifikasi kristal baru dari cdch, suatu proses untuk preparatnya dan formulasi farmasi terdiri dari modifikasi ID22625A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19546249A DE19546249A1 (de) 1995-12-12 1995-12-12 Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
ID22625A true ID22625A (id) 1999-12-02

Family

ID=7779831

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP963684A ID22625A (id) 1995-12-12 1996-12-10 Modifikasi kristal baru dari cdch, suatu proses untuk preparatnya dan formulasi farmasi terdiri dari modifikasi

Country Status (42)

Country Link
US (1) US5849752A (fr)
EP (1) EP0780390B1 (fr)
JP (1) JP4104687B2 (fr)
KR (1) KR100525146B1 (fr)
CN (1) CN1061348C (fr)
AR (1) AR005009A1 (fr)
AT (1) ATE221531T1 (fr)
AU (1) AU708006B2 (fr)
BG (1) BG62258B1 (fr)
BR (1) BR9605968A (fr)
CA (1) CA2192418C (fr)
CO (1) CO4480105A1 (fr)
CU (1) CU22774A3 (fr)
CZ (1) CZ288657B6 (fr)
DE (2) DE19546249A1 (fr)
DK (1) DK0780390T3 (fr)
EE (1) EE03474B1 (fr)
ES (1) ES2179910T3 (fr)
HR (1) HRP960558B1 (fr)
HU (1) HU226521B1 (fr)
ID (1) ID22625A (fr)
IL (1) IL119795A (fr)
IN (1) IN185805B (fr)
MA (1) MA24342A1 (fr)
MY (1) MY117492A (fr)
NL (1) NL300109I1 (fr)
NO (1) NO306725B1 (fr)
NZ (1) NZ299905A (fr)
PL (1) PL184885B1 (fr)
PT (1) PT780390E (fr)
RO (1) RO119782B1 (fr)
RU (1) RU2162468C2 (fr)
SA (1) SA96170492B1 (fr)
SG (1) SG47201A1 (fr)
SI (1) SI0780390T1 (fr)
SK (1) SK282805B6 (fr)
SV (1) SV1996000109A (fr)
TR (1) TR199600970A2 (fr)
TW (1) TW411340B (fr)
UA (1) UA35638C2 (fr)
YU (1) YU49485B (fr)
ZA (1) ZA9610405B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1017392T1 (en) * 1997-09-25 2002-12-31 Bayer Aktiengesellschaft Medicament formulation with a controlled release of an active agent
DE19751948A1 (de) 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
SI1128831T1 (en) * 1998-11-10 2005-04-30 Bayer Healthcare Ag Pharmaceutical moxifloxacin preparation
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854356A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) * 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
US20060252789A1 (en) * 2002-10-31 2006-11-09 Sujay Biswas Amorphous moxifloxacin hydrochloride
CA2521398C (fr) * 2003-04-09 2011-03-22 Dr. Reddy's Laboratories Limited Forme cristalline iii de chlorhydrate de moxifloxacine anhydre et procede de preparation de cette derniere
EP1651630A1 (fr) * 2003-08-05 2006-05-03 Matrix Laboratories Ltd Procede ameliore permettant de preparer un hydrochlorure de moxifloxacine
ITMI20032259A1 (it) 2003-11-20 2005-05-21 Chemi Spa Nuovo polimorfo dell'acido 1-ciclopropil-7-(s,s-2,8-diazabciclo-4.3.0-non-8-il)-6-fluoro-1,4-diidro-8-metossi-4-oxo-chinolin carbossilico cloridrato e metodi per la sua preparazione
EP1685130B1 (fr) * 2003-11-20 2008-12-10 CHEMI S.p.A. Polymorphes d'hydrochlorure d'acide 1-cyclopropyl-7-([s,s]-2,8-diazadicyclo[4.3.0]non-8-yl)-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylique, et leurs methodes de preparation
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
DE102004063347A1 (de) * 2004-12-23 2006-07-13 Stada Arzneimittel Ag Gebrauchsfertige Gemcitabinlösungen und Gemcitabinlösungskonzentrate
WO2007033515A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation orale contenant de la moxifloxacine et son procédé de préparation
GB0612422D0 (en) * 2006-06-23 2006-08-02 Generics Uk Ltd Novel hydrate form
US20100204470A1 (en) 2006-06-27 2010-08-12 Sandoz Ag method for salt preparation
ES2303768B1 (es) * 2006-09-08 2009-06-05 Quimica Sintetica, S.A. Nueva forma cristalina de moxifloxacino clorhidrato.
AU2007320997B2 (en) * 2006-11-13 2012-11-08 Cipla Limited Process for the synthesis of moxifloxacin hydrochloride
EP1992626A1 (fr) * 2007-05-10 2008-11-19 Sandoz AG Procédé de préparation de chlorure de moxifloxacine
EP2083010A1 (fr) * 2008-01-08 2009-07-29 Chemo Ibérica, S.A. Formes polymorphes d'hydrochlorure de moxifloxacine et leurs procédés de préparation
EP2154137A1 (fr) 2008-08-04 2010-02-17 Chemo Ibérica, S.A. Formule cristalline à base de moxifloxacine
JP5461565B2 (ja) * 2008-10-09 2014-04-02 アブディ イブラヒム イラク サナイ ベ ティカレット アノニム シルケティ 有機溶媒を使用したモキシフロキサシンの湿式造粒法
WO2010052726A1 (fr) * 2008-11-06 2010-05-14 Hetero Research Foundation Polymorphe inédit de l'hydrochlorure de moxifloxacine
WO2010066385A1 (fr) 2008-12-08 2010-06-17 Ratiopharm Gmbh Moxifloxacine compactée
WO2010131054A1 (fr) 2009-05-15 2010-11-18 Bradford Pharma Limited Dérivés redox de médicaments
WO2011121596A2 (fr) * 2010-04-01 2011-10-06 Neuland Laboratories Ltd. Modification cristalline de chlorhydrate de moxifloxacine
BRPI1106900A2 (pt) 2011-12-26 2013-11-05 Ems Sa Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
FR2992218B1 (fr) 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN102924449B (zh) * 2012-10-30 2015-08-12 重庆福安药业集团庆余堂制药有限公司 盐酸莫西沙星h晶型及其制备方法和药物组合物
WO2014087292A1 (fr) 2012-12-04 2014-06-12 Mankind Research Centre Procédé perfectionné pour la préparation de chlorhydrate de moxifloxacine
RU2561037C2 (ru) * 2013-02-07 2015-08-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Антибактериальная фармацевтическая композиция и способ ее получения
MX2015011760A (es) 2013-03-15 2016-06-10 Melinta Therapeutics Inc Metodos para tratar infecciones en pacientes obesos y con sobrepeso usando antibioticos.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
NO871333L (no) * 1986-03-31 1987-10-01 Sankyo Co Kinolin-3-karboksylsyrederivater, fremgangsmaate til fremstilling og anvendelse derav.
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
TW209865B (fr) 1992-01-10 1993-07-21 Bayer Ag
ATE207479T1 (de) * 1992-01-31 2001-11-15 Chugai Pharmaceutical Co Ltd Kristalle von derivaten von chinozon carbonsäure- hydraten
DE4234078A1 (de) 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
NO301165B1 (no) * 1992-12-25 1997-09-22 Daiichi Seiyaku Co Bicykliske aminderivater og antibakterielle midler inneholdende disse
ZA946853B (en) * 1993-09-10 1995-04-24 Daiichi Seiyaku Co Crystals of antimicrobial compound.
DK0676199T3 (da) * 1994-04-07 1999-02-08 Pfizer Anvendelse af trovafloxacin eller derivater deraf til fremstilling af et medikament til behandling af H. pylori-infektione

Also Published As

Publication number Publication date
CZ364696A3 (en) 1997-07-16
ATE221531T1 (de) 2002-08-15
UA35638C2 (uk) 2001-04-16
YU49485B (sh) 2006-08-17
RO119782B1 (ro) 2005-03-30
DK0780390T3 (da) 2002-11-11
HUP9603428A2 (en) 1997-08-28
PL184885B1 (pl) 2003-01-31
CN1160052A (zh) 1997-09-24
SK282805B6 (sk) 2002-12-03
SV1996000109A (es) 1997-10-23
NO306725B1 (no) 1999-12-13
EP0780390A1 (fr) 1997-06-25
EP0780390B1 (fr) 2002-07-31
SK159196A3 (en) 1997-10-08
EE9600201A (et) 1997-06-16
ZA9610405B (en) 1997-06-23
SG47201A1 (en) 1998-03-20
SA96170492B1 (ar) 2006-05-23
IL119795A (en) 1998-12-27
IL119795A0 (en) 1997-03-18
YU65096A (sh) 1998-12-23
HRP960558B1 (en) 2002-04-30
MY117492A (en) 2004-07-31
CA2192418A1 (fr) 1997-06-13
SI0780390T1 (en) 2002-10-31
IN185805B (fr) 2001-05-05
BR9605968A (pt) 1998-08-18
TW411340B (en) 2000-11-11
AR005009A1 (es) 1999-04-07
AU7421696A (en) 1997-06-19
CU22774A3 (es) 2002-07-24
KR970042550A (ko) 1997-07-24
NO965298L (no) 1997-06-13
BG101043A (en) 1998-04-30
NL300109I1 (nl) 2003-02-03
CA2192418C (fr) 2001-06-12
BG62258B1 (bg) 1999-06-30
MA24342A1 (fr) 1998-07-01
JP4104687B2 (ja) 2008-06-18
KR100525146B1 (ko) 2006-01-27
HU226521B1 (en) 2009-03-30
NO965298D0 (no) 1996-12-11
AU708006B2 (en) 1999-07-29
HUP9603428A3 (en) 1997-10-28
NZ299905A (en) 1998-09-24
PL317415A1 (en) 1997-06-23
US5849752A (en) 1998-12-15
RU2162468C2 (ru) 2001-01-27
PT780390E (pt) 2002-11-29
EE03474B1 (et) 2001-08-15
DE59609501D1 (de) 2002-09-05
CO4480105A1 (es) 1997-07-09
HRP960558A2 (en) 1998-02-28
MX9606325A (es) 1997-10-31
CZ288657B6 (cs) 2001-08-15
JPH09169757A (ja) 1997-06-30
HU9603428D0 (en) 1997-01-28
TR199600970A2 (tr) 1997-06-21
CN1061348C (zh) 2001-01-31
DE19546249A1 (de) 1997-06-19
ES2179910T3 (es) 2003-02-01

Similar Documents

Publication Publication Date Title
ID22625A (id) Modifikasi kristal baru dari cdch, suatu proses untuk preparatnya dan formulasi farmasi terdiri dari modifikasi
BR9604894A (pt) Derivado de acetamida processo para a preparação do mesmo e uma composição farmacêutica contendo o mesmo
BR9600821A (pt) Composto formulação farmacêutica e processo para a preparação de um composto
AU5471996A (en) Process for the preparation of microcapsule compositions
NO981150D0 (no) Konsentrert, flytende vaskemiddelblanding og fremgangsmåte for fremstilling av denne
ZA962916B (en) New arylglycineamide derivatives processes for the manufacture thereof and pharmaceutical compositions containing these compounds
ID25516A (id) Senyawa-senyawa yang mengandung cincin-cincin beranggotakan enam, proses pembuatannya, dan penggunaannya sebagai obat
BR9708014A (pt) Derivados de arilglicinamida processo para a preparação deles e composições farmacêuticas contendo estes compostos
AU6611396A (en) New oxazolidinone derivatives, processes for the production thereof and pharmaceutical agents containing these compounds
NO306620B1 (no) Fremgangsmåte for fremstilling av polydimetylsiloksaner
NO982237D0 (no) Ny fremgangsmÕte for fremstilling av fenylimidazolidinderivater
NO973460D0 (no) Fremgangsmåte for gjenvinning av kvikksölv
ID24173A (id) 1,2,3,4,5,6 heksahidro-2-6-metano-3-benzazosin-10-ol, proses pembuatan dan penggunannya untuk obat-obatan
ID20967A (id) Kroman tersubstitusi sulfonamida, proses pembuatannya, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung bahan tersebut
NO941659L (no) Fremgangsmåte for fremstilling av aluminoksaner
NO961484D0 (no) Fremgangsmåte til undersökelse av silanbehandlede, uorganiske materialer
NO974155D0 (no) Ny fremgangsmåte for fremstilling av 2,3-dihydrobenzofuranolderivater
NO960307D0 (no) Fremgangsmåte ved fremstilling av substituerte 4,6-diamino-5-cyanopyrimidiner
PT92345A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados diterpenoides de labdano e derivados de pirimido(6,1-a)isoquinolina-4-ona
ID20968A (id) Kroman tersubstitusi sulfonamida, proses pembuatannya, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung bahan tersebut
NO20003393D0 (no) FremgangsmÕte for fremstilling av en farmasøytisk formulering
ID17177A (id) Benzoilguanidin tersubstitusi sulfonilamino, suatu proses pembuatannya dan penggunaannya sebagai suatu obat atau diagnostik, dan obat yang tersusun dari senyawa tersebut
NO982503D0 (no) FremgangsmÕte ved fremstilling av dioksoazabicykloheksaner
NO961008D0 (no) Fremgangsmåte for fremstilling av cykliske cis-1-amino-2-alkanoler
ID22627A (id) Steroid-steroid yang disubstitusikan dalam posisi 11, proses pembuatannya, penggunaannya sebagai obat-obatan dan senyawa-senyawa farmasi yang mengandungnya